Table 2.
Prevalence of functional gastrointestinal disorders categories for ROME III (with and without 6-mo requirement) and ROME II (with 3-mo requirement)
|
ROME III cohort (n = 100) |
ROME II cohort (n = 160) | ||
| With 6-mo requirement | With 3-mo requirement | Present 3 mo or more | |
| Region | |||
| A: Functional Esophageal Disorders | 34% | 55% | 40% |
| B: Functional Gastroduodenal Disorders | 62% | 79% | 16% |
| Without cyclic vomiting | 45% | 60% | |
| C: Functional Bowel Disorders | 77% | 98% | 88% |
| Without unspecified bowel disease | 53% | 80% | |
| D: Functional Abdominal Pain Syndrome | 3% | 6% | 4% |
| E: Functional Gallbladder and Sphincter of Oddi Disorders | 0% | 2% | |
| F: Functional Anorectal Disorders1 | 16% | 20% | 35% |
| Total | |||
| At least one FGID | 83% | 94% | |
| At least 3 FGIDs | 34% | 36% | |
1
Two ROME III functional gastrointestinal disorders (FGIDs) within the functional anorectal disorder category are for 3 mo only (and F1. Functional Fecal Incontinence not included).